• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » How to Diagnose Bipolar Disorder

How to Diagnose Bipolar Disorder

November 5, 2021
Gordon Parker, MD, PhD, DSc.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Gordon Parker, MD, PhD, DScGordon Parker, MD, PhD, DSc. Scientia Professor of psychiatry at the University of New South Wales. In 2002 he founded the Black Dog Institute, a clinical research center for mood disorders. Dr. Parker’s research has focused on the phenomenology and diagnosis of depression and bipolar disorder. Dr. Parker has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

TCPR: When I ask a depressed patient if they’ve ever had manic symptoms, I often run into a problem. They say, “Of course I feel more confident, energetic, and happy ... when I’m not depressed.”
Dr. Parker: As it can be hard to tease apart true hypomania from normal happiness, we’ve developed a rating scale to assist, the Sydney Bipolar Screener. We evaluated 94 symptoms of mania and hypomania in patients who were already diagnosed with bipolar or unipolar disorder. We asked the patients with bipolar disorder to check the items that reflected their “highs,” and the unipolar patients to check the items that described times when they were “happy.” We used a machine learning strategy to filter out the items that overlapped with normal happiness. In the end, that whittled the set down to 10 symptoms that separated bipolar from unipolar with a high predictive accuracy—over 90% (Parker G et al, J Affect Disord 2021;281:505–509). (Editor’s note: See The Sydney Bipolar Screener table below.)


TCPR: What is the main thing that separates out the bipolars?
Dr. Parker: Energy. The most distinguishing item was “I have very high levels of energy.” Items related to euphoria and heightened emotions didn’t make the cut. One item that didn’t make the top 10 but that we do see a lot in mania and hypomania is decreased need for sleep. I think the key issue is not just asking “Do you need less sleep?” but extending the question by saying “Do you sleep less and find that you’re not tired the next day?”


TCPR: What’s your top screening question for bipolar disorder?
Dr. Parker: The first screening question I use in my clinical assessment is, “Apart from the times when you’re depressed and when your mood is normal, do you have periods when you’re energized and wired?” This puts energy front and center. Energy was not part of the core “Criterion A” definition of mania in DSM-IV, but they brought it in for DSM-5, which I think was wise.


TCPR: You’re leading a task force that is proposing changes to DSM criteria for mania and hypomania. How would you change the core definition: “A distinct period of abnormally and persistently elevated, expansive or irritable mood and abnormally and persistently goal-directed behavior or energy”?
Dr. Parker: We have a minor tweak for that one. We’d emphasize that the elevated mood is not just happiness but is an “overshoot.” Thus: “A distinct period of abnormal and persistently elevated, expansive, or irritable mood, with the individual feeling energized and ‘wired,’ and which is perceived as an ‘overshoot’ and not simply a state of happiness, and generally oscillating with periods of depression.”


TCPR: You also added a part about cycling with depression.
Dr. Parker: That can help reduce false positives. I think it’s very rare for people to only have hypomanic or manic episodes without depressions. In my experience, I’ve seen maybe three or four people like that over my lifetime.


TCPR: Are bipolar depressions different from unipolar depressions?
Dr. Parker: Bipolar depression is more likely to be melancholic, and possibly psychotic. When I say “melancholic,” I’m not referring to the DSM criteria for melancholic features. I’m speaking more generally of a severe depressed state where their mood is nonreactive, they have anhedonia, a distinct lack of energy, foggy concentration, and maybe other psychomotor changes. So when I want to establish a diagnosis of bipolar disorder, I look for manic features but I also check out the nature of their depressions.


TCPR: What else would you change in the DSM criteria for bipolar?
Dr. Parker: Another problem is how the DSM separates mania from hypomania. First, the use of the same list of symptoms for both states is problematic. To separate them, the DSM uses severity (mania causes significant impairment), duration (hypomania is at least four days while mania is at least seven days), and hospitalization and psychotic features (these last two automatically shift the diagnosis to mania). I don’t know of any other medical condition where hospitalization is a criterion. It depends too much on external variables like social supports and the health care system.


TCPR: What about duration?
Dr. Parker: The problem there is that the four- and seven-day cutoffs the DSM uses for hypomania and mania have never been empirically validated. Patients who meet the full duration criterion have the same clinical features as those whose elevated moods are classic and recurrent, but shorter in duration (Parker G and Fletcher K, J Affect Disord 2014;152–154:57–64). Even when patients meet the full duration criterion, their typical episodes tend to be shorter. For 60% of patients with bipolar II, the average episode of hypomania lasts fewer than four days, and for 40% of patients with bipolar I, the average mania lasts fewer than seven days. In practice, when you ask a patient how long their episodes last, their answer is likely to reflect their typical episode, which means you’ll miss a lot of people with true bipolar disorder by applying the DSM-5 duration criterion.


TCPR: A lot of papers have argued for reducing the duration, particularly with hypomania. Why has DSM stuck with it?
Dr. Parker: I think they’re being conservative and trying to respect concerns about overdiagnosis, but I think those concerns can be addressed by more precise definitional criteria rather than by a “safety” duration period. Technically DSM-5 does recognize the short-duration cases with “depressive episodes with short-duration hypomania,” but that’s in the back of the book as a “condition for further study.”


TCPR: What separates mania from hypomania in your view?
Dr. Parker: For me, it is the presence of psychotic features. If you have psychosis during an elevated state, it’s bipolar I. If you don’t, then it’s bipolar II.


TCPR: Do you mean delusions and hallucinations, or do you take a broader view of psychosis, including distorted thinking and thought-blocking?
Dr. Parker: I’m speaking just of delusions and hallucinations. These aren’t always easy to diagnose, as there is a fine line between a delusion and an overvalued idea. For example, the average patient becomes grandiose during a high. They think they’re going to be the boss of the company or write the great Australian novel. To diagnose psychosis, I look for pretty black-and-white features such as, “When I’m high, I have a voice in my head telling me I am God.” I’m looking for distinctive and clear-cut psychotic delusions or hallucinations.


TCPR: There is also a fine line between heightened sensations and hallucinations.
Dr. Parker: Yes, and that’s important to recognize because patients with both bipolar I and bipolar II tend to have highly sensitive perceptions, but I would not classify those as hallucinations (Parker G et al, Australas Psychiatry 2018;26(4):384–387). I have patients that will say, “I can hear a car in the street three blocks away” and I can’t hear anything. Smells are more powerful. One patient stepped on some dog poo while in an elevated mood—they wiped it off, but they could smell it for the whole day. Sometimes these sensations are a source of creativity. One patient told me when she’s listening to an orchestra, she has the capacity to bring out and separate every instrument and then rejoin them together.


TCPR: Does a patient’s judgment tell you about possible delusional thinking? For example, suppose a patient with bipolar disorder tells you they’ve taken out all their retirement savings to start a chain of ice cream stores. They teach elementary school and have no business experience. That’s out of touch with reality, but is it delusional?
Dr. Parker: I would strongly consider psychosis in that case because it suggests delusional confidence. On the other hand, if a multimillionaire took out $200,000 to start a new business, I’d be less inclined to think it was delusional. Mania and hypomania also tend to differ in how the patient recalls the episode. After the episode, the hypomanic patient is likely to feel great shame about what they did while the manic patient may not remember it or be inclined to deny it.


TCPR: One way the DSM separates mania from hypomania is by the level of impairment. What’s wrong with that definition?
Dr. Parker: The DSM wording is imprecise: “marked impairment” for mania and “not severe enough to cause marked impairment” in hypomania. How are clinicians meant to judge the difference? Further, it puts the weight on impairment, when in reality there’s a significant percentage of patients with mania and hypomania who say their functioning is distinctly improved, and they may well be right if creativity or productivity is the benchmark for functioning.


TCPR: Getting back to hypomania vs normal happiness, is there a clear, categorical line between them, or are they on a continuum?
Dr. Parker: Our studies support a categorical view. When we plot the answers to a bipolar screening measure, we observe a bimodal distribution, so there is a clear separation between normal elevated mood and the hypomania of bipolar disorder. And when we throw in bipolar I patients we get a trimodal distribution, so there is a categorical separation between hypomania and mania as well (Parker G et al, Psychiatry Res 2021;297:113719).


TCPR: Sometimes it doesn’t seem so clear cut in practice.
Dr. Parker: In clinical practice, about 2% or 3% of patients who present for evaluation of bipolar have hypomanias that are so mild that I’m not entirely sure that they’ve truly got bipolar disorder, but it’s a very, very small minority. If you go through the diagnostic steps, you can usually identify the patients with true bipolar disorder.


TCPR: What are those steps?
Dr. Parker: Start with a screening question, like the one I suggested about energy. If they say “no” or are unsure, double-check by asking, “You don’t have times when you are more energized, elated, and overconfident, in a way that is distinct from your normal self?” If one of those tries is a “yes,” move forward and check for the rest of the DSM symptoms of hypomania/mania. Ideally, you want to identify clear and unequivocal episodes of hypomania or mania. Then ask about the depressive phases. Are the depressions recurrent and cyclical? Do at least some of them have melancholic features in the way I described? Next, I would look for a family history. Patients with true bipolar disorder will almost invariably report a family history of either depression or bipolar in their first- or second-degree relatives. About half will report bipolar in their family, but the other half will usually report depression (Suppes T et al, J Affect Disord 2001;67(1–3):45–59).


TCPR: Anything else?
Dr. Parker: Finally, age of onset can also be helpful, as most bipolar disorder starts in adolescence, particularly between ages 15 and 20. Age of onset is a strong indicator, and it can help to differentiate bipolar disorder from other conditions that share some symptomatic overlap with hypomania, like ADHD and borderline personality disorder. Those two disorders tend to start much earlier. (Editor’s note: Borderline personality disorder cannot be diagnosed until age 18, but adults with this disorder can usually trace some of their symptoms back to early childhood.)


TCPR: If the patient checks all those boxes, are you pretty sure they have bipolar disorder?
Dr. Parker: Yes, and I’ll tell them that. I always apologize first and say, “This is going to sound a bit arrogant, but I believe with a 100% level of confidence that you’ve got (say) bipolar II.” Or if I’m not 100% confident, I’ll say so and explain why. It may be that they don’t check all the boxes, or there are other things going on like substance use that might explain the symptoms. And then I’ll detail what needs to be done to obtain a firmer diagnosis.


TCPR: You’re very direct about it. How do patients respond?
Dr. Parker: They seem to appreciate a firm diagnosis as it allows them to get on with their lives. They now know what they’ve got and they can go on Google and read about it. And, of course, you hope to find the right medication and they’ll have it all come under control. I believe that most people with a bipolar condition do well when we find right medication.


TCPR: The right medication may be different for everyone, but what are the go-to meds that you often start with?
Dr. Parker: My preferred drugs are lithium for bipolar I and lamotrigine for bipolar II.


TCPR: Thank you for your time, Dr. Parker.



Table: The Sydney Bipolar Screener


Table: The Sydney Bipolar Screener


(Click to view full-sized PDF.)



 



podcastsStay tuned for our podcast, “A New Way to Diagnose Bipolar: An Interview With Gordon Parker.” Search for “Carlat” on your podcast store.


General Psychiatry
KEYWORDS bipolar-depression bipolar-ii bipolar_disorder diagnosis dsm hypomania mania mixed-features mood
    Qa1 gordon parker headshot 150x150
    Gordon Parker, MD, PhD, DSc.

    More from this author
    www.thecarlatreport.com
    Issue Date: November 5, 2021
    SUBSCRIBE NOW
    Table Of Contents
    How to Treat ADHD in Bipolar Disorder
    In the News: Aducanumab (Aduhelm)
    Viloxazine for ADHD
    Listening to Depression: The Importance of Addressing Hearing Loss
    Establishing a Dose-Response Relationship for Lurasidone in Acute Schizophrenia
    Sleepwalking on Antipsychotics and Lithium
    In Brief: Meds in the Fast Lane
    How to Diagnose Bipolar Disorder
    Nutritional Psychiatry in Practice
    CME Post-Test - Bipolar Disorder, TCPR, November/December 2021
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.